New Platform for Affordable Genomic Cancer Profiling Launched
A next-generation sequencing reference laboratory will use artificial intelligence (AI) to advance precision medicine to determine genomic signatures, first for [...]
What Do Trump’s Drug Pricing Orders Mean, Other than Confusion?
Consistent with the status quo chaos that surrounds the White House, the Trump Administration's four drug pricing executive orders unveiled [...]
Lilly Partners with Prime Therapeutics: How Next Generation Value-based Arrangements Put Patients First
Value-based arrangements (VBA) are increasingly used, although most medicines are paid based on volume of product purchased or cost per [...]
Going on Now! AcademyHealth 2020 is Virtual Yet Vital: Here’s Why
Kicking off today, AcademyHealth 2020 will provide vital insights over a 2-week period from July 28 – August 6 with [...]
Showdown: White House Cancels Pharma Meeting on International Pricing
On Tuesday, July 28, the White House abruptly canceled a meeting with drug company executives to discuss the most favored [...]
Applications Sought for AMCP Board; Deadline is September 2
AMCP is seeking board members for the position of president-elect, treasurer, and two directors. Qualified candidates will possess the following competencies: [...]
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018
Kim et. al. of Tufts Medical Center published an examination in the journal Pharmacoeconomics assessing CEA and Global Health CEA [...]
ISPOR Offering Course on Causal Inference in Observational, Pragmatic Trials
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering a 4-hour course on causal inference in observational data [...]
IFAPP, MAPS Course Offers Certificate in Medicine Development
An online course hosted by IFAPP Academy in partnership with the Medical Affairs Professional Society (MAPS) aims to give medical [...]
Rho Experts to Explore Decentralized Trials
Rho's Rob Woolson and Derek Lawrence will discuss in an upcoming webinar how the company is helping trial sponsors get [...]
Former FDA Chief Talks Value-Based Care, Medical Tech
In a new Patients Rising podcast, former FDA Chief Mark McClellan explores how the COVID-19 pandemic has revealed the benefits [...]
ISPOR Webinar on Leadership Skills Nears
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) "Pathways to ISPOR Leadership" webinar is right around the corner. Registration [...]
Aetna Launching 2 New Plan Benefit Designs
Aetna announced plans to launch two new plan benefit designs aimed at addressing growing concerns by employers about high-deductible plans, [...]
NPC: CMS Proposed Rule Hinders Value-Based Arrangements
In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues [...]
Biotech Company Looks to Create Cheaper Alternatives to Pfizer, AstraZeneca Drugs
EQRX, a private biotech company launched in January, is looking to create cheaper alternatives to Pfizer's Ibrance and AstraZeneca's Tagrisso, [...]
Shulkin: COVID-19 Laying Foundation for ‘Tsunami of Challenges’ for Health System
David Shulkin, former secretary of the Department of Veterans Affairs, says the COVID-19 crisis is ultimately generating a "tsunami of [...]
Analysis Suggests 80% of New RA, MS Patients Face Utilization Management Restrictions
Roughly 80 percent of commercially-insured patients face utilization management restrictions when attempting to fill a new prescription for rheumatoid arthritis [...]
NAMCP Looks to Streamline Sharing of Value Propositions
The National Association of Managed Care Physicians' Value Based Care Council says its newly-developed short form streamlines how value propositions [...]
Reminder: ICER Webinar on Cost-Recovery Pricing for COVID-19 Drugs is Tomorrow
The first installment of the Institute for Clinical and Economic Review's (ICER) three-part webinar series on drug pricing models for [...]
Paper Looks at Impact of Coverage Policies on Pharma Incentives
A recently-published study by Leila Agha, Soomi Kim and Danielle Li analyzes how insurance coverage policies impact incentives for innovation [...]
Article: Drug Pricing Back in Spotlight
With the race for COVID-19 treatments and a vaccine well under way, the issue of drug pricing is again front [...]
MAPS Appoints Pracyk as President
The Medical Affairs Professional Society (MAPS) appointed its new president of the Americas region, John Pracyk. MAPS in an announcement [...]
ICER Posts Evidence Report on Obeticholic Acid for NASH
The Institute for Clinical and Economic Review (ICER) on Monday, July 21, posted an evidence report on Intercept Pharmaceuticals' obeticholic [...]
Article Spotlights Virtual Component of ADAPTABLE Study
A recent Clinical Leader article spotlights how the ADAPTABLE study, which was launched in 2016 by PCORI and the Duke [...]
Webinar to Highlight Challenges of Value Assessment Amid Pandemic
An upcoming webinar sponsored by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Innovation and Value Initiative [...]